Artykuły w czasopismach na temat „Fsp1”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Fsp1”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Nwagala, P. N., S. A. Bankole i O. A. F. Ilusanya. "Isolation and molecular characterization of cellulase-producing bacteria from waste dump site". Scientia Africana 23, nr 1 (30.03.2024): 73–84. http://dx.doi.org/10.4314/sa.v23i1.6.
Pełny tekst źródłaKong, Ping, Panagiota Christia, Amit Saxena, Ya Su i Nikolaos G. Frangogiannis. "Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis". American Journal of Physiology-Heart and Circulatory Physiology 305, nr 9 (1.11.2013): H1363—H1372. http://dx.doi.org/10.1152/ajpheart.00395.2013.
Pełny tekst źródłaHou, Wanyun, Puze Long, Xilin Liu, Fahui Liu, Jiadong Liang, Yunmei Huang, Qunying Su, Lihe Jiang i Chunying Luo. "CISD2 protects against Erastin induced hepatocellular carcinoma ferroptosis by upregulating FSP1". Oncologie 25, nr 3 (30.03.2023): 269–79. http://dx.doi.org/10.1515/oncologie-2023-0074.
Pełny tekst źródłaNakamura, Toshitaka, Eikan Mishima, Naoya Yamada, André Santos Dias Mourão, Dietrich Trümbach, Sebastian Doll, Jonas Wanninger i in. "Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation". Nature Structural & Molecular Biology 30, nr 11 (listopad 2023): 1806–15. http://dx.doi.org/10.1038/s41594-023-01136-y.
Pełny tekst źródłaLee, Jaewang, i Jong-Lyel Roh. "Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance". Antioxidants 12, nr 6 (5.06.2023): 1218. http://dx.doi.org/10.3390/antiox12061218.
Pełny tekst źródłaÖsterreicher, Christoph H., Melitta Penz-Österreicher, Sergei I. Grivennikov, Monica Guma, Ekaterina K. Koltsova, Christian Datz, Roman Sasik, Gary Hardiman, Michael Karin i David A. Brenner. "Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver". Proceedings of the National Academy of Sciences 108, nr 1 (20.12.2010): 308–13. http://dx.doi.org/10.1073/pnas.1017547108.
Pełny tekst źródłaStrutz, F., H. Okada, C. W. Lo, T. Danoff, R. L. Carone, J. E. Tomaszewski i E. G. Neilson. "Identification and characterization of a fibroblast marker: FSP1." Journal of Cell Biology 130, nr 2 (15.07.1995): 393–405. http://dx.doi.org/10.1083/jcb.130.2.393.
Pełny tekst źródłaOkada, Hirokazu, Theodore M. Danoff, Raghuram Kalluri i Eric G. Neilson. "Early role of Fsp1 in epithelial-mesenchymal transformation". American Journal of Physiology-Renal Physiology 273, nr 4 (1.10.1997): F563—F574. http://dx.doi.org/10.1152/ajprenal.1997.273.4.f563.
Pełny tekst źródłaGotorbe, Célia, Jérôme Durivault, Willian Meira, Shamir Cassim, Maša Ždralević, Jacques Pouysségur i Milica Vučetić. "Metabolic Rewiring toward Oxidative Phosphorylation Disrupts Intrinsic Resistance to Ferroptosis of the Colon Adenocarcinoma Cells". Antioxidants 11, nr 12 (6.12.2022): 2412. http://dx.doi.org/10.3390/antiox11122412.
Pełny tekst źródłaDixit, Vishwa, Yun-Hee Youm, Hyunwon Yang, Christo Venkov, Nancy Manley, Eric Nielson, Todd Leff i Bolormaa Vandanmagsar. "Origin of Thymic Adipocytes in Aging: Incidental to Thymopoiesis or Instigator of Immunosenescence? (132.22)". Journal of Immunology 184, nr 1_Supplement (1.04.2010): 132.22. http://dx.doi.org/10.4049/jimmunol.184.supp.132.22.
Pełny tekst źródłaBryja, Artur, Wojciech Pieńkowski, Katarzyna Stefańska, Błażej Chermuła, Rut Bryl, Maria Wieczorkiewicz, Jakub Kulus i in. "Analysis of TGFB1, CD105 and FSP1 expression in human granulosa cells during a 7-day primary in vitro culture". Medical Journal of Cell Biology 8, nr 4 (1.12.2020): 152–57. http://dx.doi.org/10.2478/acb-2020-0019.
Pełny tekst źródłaOkada, Hirokazu, Theodore M. Danoff, Andreas Fischer, Jesus M. Lopez-Guisa, Frank Strutz i Eric G. Neilson. "Identification of a novelcis-acting element for fibroblast-specific transcription of theFSP1 gene". American Journal of Physiology-Renal Physiology 275, nr 2 (1.08.1998): F306—F314. http://dx.doi.org/10.1152/ajprenal.1998.275.2.f306.
Pełny tekst źródłaBebber, Christina M., i Silvia von Karstedt. "FSP1 inhibition: pick your pocket". Nature Structural & Molecular Biology 30, nr 11 (listopad 2023): 1618–19. http://dx.doi.org/10.1038/s41594-023-01145-x.
Pełny tekst źródłaLee, Keunwook, Kelli L. Boyd, Diptiben V. Parekh, Thomas E. Kehl-Fie, H. Scott Baldwin, Cord Brakebusch, Eric P. Skaar, Mark Boothby i Roy Zent. "Cdc42 Promotes Host Defenses against Fatal Infection". Infection and Immunity 81, nr 8 (20.05.2013): 2714–23. http://dx.doi.org/10.1128/iai.01114-12.
Pełny tekst źródłaYang, Kezhen, Lingling Zhu, Hongzhe Wang, Min Jiang, Chunwang Xiao, Xiangyang Hu, Steffen Vanneste, Juan Dong i Jie Le. "A conserved but plant-specific CDK-mediated regulation of DNA replication protein A2 in the precise control of stomatal terminal division". Proceedings of the National Academy of Sciences 116, nr 36 (20.08.2019): 18126–31. http://dx.doi.org/10.1073/pnas.1819345116.
Pełny tekst źródłaWang, Fang, Jiaxi Li, Yingjie Zhao, Dong Guo, Dongfan Liu, Su'e Chang, Hao Qiao i in. "miR-672-3p Promotes Functional Recovery in Rats with Contusive Spinal Cord Injury by Inhibiting Ferroptosis Suppressor Protein 1". Oxidative Medicine and Cellular Longevity 2022 (21.02.2022): 1–19. http://dx.doi.org/10.1155/2022/6041612.
Pełny tekst źródłaYadav, Anju, Sridevi Vallabu, Dileep Kumar, Guohua Ding, Douglas N. Charney, Praveen N. Chander i Pravin C. Singhal. "HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation". American Journal of Physiology-Renal Physiology 298, nr 3 (marzec 2010): F734—F744. http://dx.doi.org/10.1152/ajprenal.00415.2009.
Pełny tekst źródłaDoll, Sebastian, Florencio Porto Freitas, Ron Shah, Maceler Aldrovandi, Milene Costa da Silva, Irina Ingold, Andrea Goya Grocin i in. "FSP1 is a glutathione-independent ferroptosis suppressor". Nature 575, nr 7784 (21.10.2019): 693–98. http://dx.doi.org/10.1038/s41586-019-1707-0.
Pełny tekst źródłaWei, Xiang, Xin Yi, Xue-Hai Zhu i Ding-Sheng Jiang. "Posttranslational Modifications in Ferroptosis". Oxidative Medicine and Cellular Longevity 2020 (26.11.2020): 1–12. http://dx.doi.org/10.1155/2020/8832043.
Pełny tekst źródłaCheng, Hao, Pengfei Wang, Ning Wang, Wenwen Dong, Ziyuan Chen, Mingzhe Wu, Ziwei Wang i in. "Neuroprotection of NRF2 against Ferroptosis after Traumatic Brain Injury in Mice". Antioxidants 12, nr 3 (16.03.2023): 731. http://dx.doi.org/10.3390/antiox12030731.
Pełny tekst źródłaIwano, Masayuki, Yukinari Yamaguchi, Takaaki Iwamoto, Kimihiko Nakatani, Masaru Matsui, Atsushi Kubo, Yasuhiro Akai, Toshio Mori i Yoshihiko Saito. "Urinary FSP1 Is a Biomarker of Crescentic GN". Journal of the American Society of Nephrology 23, nr 2 (17.11.2011): 209–14. http://dx.doi.org/10.1681/asn.2011030229.
Pełny tekst źródłaMishima, Eikan, Toshitaka Nakamura, Jiashuo Zheng, Weijia Zhang, André Santos Dias Mourão, Peter Sennhenn i Marcus Conrad. "DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition". Nature 619, nr 7968 (5.07.2023): E9—E18. http://dx.doi.org/10.1038/s41586-023-06269-0.
Pełny tekst źródłaDeng, Chun, Jin Wang, Youfu Zou, Qianqian Zhao, Jie Feng, Zhou Fu i Chunbao Guo. "Characterization of fibroblasts recruited from bone marrow-derived precursor in neonatal bronchopulmonary dysplasia mice". Journal of Applied Physiology 111, nr 1 (lipiec 2011): 285–94. http://dx.doi.org/10.1152/japplphysiol.00201.2010.
Pełny tekst źródłaYang, Kun, Jiaran Shi, Zhujun Hu i Xiaosheng Hu. "The deficiency of miR-214-3p exacerbates cardiac fibrosis via miR-214-3p/NLRC5 axis". Clinical Science 133, nr 17 (wrzesień 2019): 1845–56. http://dx.doi.org/10.1042/cs20190203.
Pełny tekst źródłaAdamiec-Organisciok, Malgorzata, Magdalena Wegrzyn, Lukasz Cienciala, Damian Sojka, Joanna Nackiewicz i Magdalena Skonieczna. "Compensative Resistance to Erastin-Induced Ferroptosis in GPX4 Knock-Out Mutants in HCT116 Cell Lines". Pharmaceuticals 16, nr 12 (10.12.2023): 1710. http://dx.doi.org/10.3390/ph16121710.
Pełny tekst źródłaLemberger, U. J., M. Penz-Österreicher, D. Brenner, M. Trauner i C. H. Österreicher. "P167 LACK OF FSP1/S100A4 ATTENUATES LIVER FIBROSIS IN MICE". Journal of Hepatology 60, nr 1 (kwiecień 2014): S122. http://dx.doi.org/10.1016/s0168-8278(14)60329-9.
Pełny tekst źródłaZhang, Rui, Yuan Gao, Xiaotong Zhao, Mei Gao, Yanjun Wu, Yingying Han, Yuemei Qiao i in. "FSP1-positive fibroblasts are adipogenic niche and regulate adipose homeostasis". PLOS Biology 16, nr 8 (6.08.2018): e2001493. http://dx.doi.org/10.1371/journal.pbio.2001493.
Pełny tekst źródłaYamaki, Shogo, Takuo Omachi, Yuji Kawai i Koji Yamazaki. "Characterization of a novelMorganella morganiibacteriophage FSP1 isolated from river water". FEMS Microbiology Letters 359, nr 2 (28.08.2014): 166–72. http://dx.doi.org/10.1111/1574-6968.12560.
Pełny tekst źródłaXavier da Silva, Thamara Nishida, i José Pedro Friedmann Angeli. "Sabotaging the breaks: FSEN1 expands the toolbox of FSP1 inhibitors". Cell Chemical Biology 30, nr 9 (wrzesień 2023): 1006–8. http://dx.doi.org/10.1016/j.chembiol.2023.08.015.
Pełny tekst źródłaMao, Chao, Xiaoguang Liu, Yuelong Yan, Kellen Olszewski i Boyi Gan. "Reply to: DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition". Nature 619, nr 7968 (5.07.2023): E19—E23. http://dx.doi.org/10.1038/s41586-023-06270-7.
Pełny tekst źródłaLi, Zihao, Siwen Chen, Haowen Cui, Xiang Li, Dongying Chen, Wenjun Hao, Jianru Wang i in. "Tenascin-C-mediated suppression of extracellular matrix adhesion force promotes entheseal new bone formation through activation of Hippo signalling in ankylosing spondylitis". Annals of the Rheumatic Diseases 80, nr 7 (15.04.2021): 891–902. http://dx.doi.org/10.1136/annrheumdis-2021-220002.
Pełny tekst źródłaYuan, Bin, Xu-Dong Zhao, Jun-Da Shen, Shu-Juan Chen, Han-Yu Huang, Xiao-Ming Zhou, Yan-Ling Han, Long-Jiang Zhou, Xiao-Jie Lu i Qi Wu. "Activation of SIRT1 Alleviates Ferroptosis in the Early Brain Injury after Subarachnoid Hemorrhage". Oxidative Medicine and Cellular Longevity 2022 (9.07.2022): 1–19. http://dx.doi.org/10.1155/2022/9069825.
Pełny tekst źródłaBruneval, Patrick, Jerome Rossert i Jean Bariety. "Renewal of FSP1: A marker of fibrogenesis on human renal biopsies". Kidney International 68, nr 3 (wrzesień 2005): 1366–67. http://dx.doi.org/10.1111/j.1523-1755.2005.00546.x.
Pełny tekst źródłaBersuker, Kirill, Joseph M. Hendricks, Zhipeng Li, Leslie Magtanong, Breanna Ford, Peter H. Tang, Melissa A. Roberts i in. "The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis". Nature 575, nr 7784 (21.10.2019): 688–92. http://dx.doi.org/10.1038/s41586-019-1705-2.
Pełny tekst źródłaHadian, Kamyar. "Ferroptosis Suppressor Protein 1 (FSP1) and Coenzyme Q10 Cooperatively Suppress Ferroptosis". Biochemistry 59, nr 5 (31.01.2020): 637–38. http://dx.doi.org/10.1021/acs.biochem.0c00030.
Pełny tekst źródłaHuang, Long Shuang, Tara Sudhadevi, Panfeng Fu, Prasanth-Kumar Punathil-Kannan, David Lenin Ebenezer, Ramaswamy Ramchandran, Vijay Putherickal i in. "Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts". International Journal of Molecular Sciences 21, nr 6 (17.03.2020): 2064. http://dx.doi.org/10.3390/ijms21062064.
Pełny tekst źródładen Boon, Johan A., Dohun Pyeon, Sophia S. Wang, Mark Horswill, Mark Schiffman, Mark Sherman, Rosemary E. Zuna i in. "Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling". Proceedings of the National Academy of Sciences 112, nr 25 (8.06.2015): E3255—E3264. http://dx.doi.org/10.1073/pnas.1509322112.
Pełny tekst źródłaDavis, Jennifer L., Roman Thaler, Linda Cox, Biancamaria Ricci, Heather M. Zannit, Fei Wan, Roberta Faccio, Amel Dudakovic, Andre J. van Wijnen i Deborah J. Veis. "Constitutive activation of NF-κB inducing kinase (NIK) in the mesenchymal lineage using Osterix (Sp7)- or Fibroblast-specific protein 1 (S100a4)-Cre drives spontaneous soft tissue sarcoma". PLOS ONE 16, nr 7 (22.07.2021): e0254426. http://dx.doi.org/10.1371/journal.pone.0254426.
Pełny tekst źródłaWang, Zhikui, Zhongqi Zhou, Wenjie Ji, Lina Sun, Yulin Man, Jifeng Wang i Hongjuan Zhang. "Silencing of lncRNA 6030408B16RIK prevents ultrafiltration failure in peritoneal dialysis via microRNA-326-3p-mediated WISP2 down-regulation". Biochemical Journal 477, nr 10 (29.05.2020): 1907–21. http://dx.doi.org/10.1042/bcj20190877.
Pełny tekst źródłaPoly, Frédéric, Cheryl Ewing, Scarlett Goon, Thomas E. Hickey, David Rockabrand, Gary Majam, Lanfong Lee, Julie Phan, Nicholas J. Savarino i Patricia Guerry. "Heterogeneity of a Campylobacter jejuni Protein That Is Secreted through the Flagellar Filament". Infection and Immunity 75, nr 8 (21.05.2007): 3859–67. http://dx.doi.org/10.1128/iai.00159-07.
Pełny tekst źródłaLi, Yilan, Jingru Yan, Heng Sun, Yating Liang, Qianqian Zhao, Shan Yu i Yao Zhang. "Ferroptosis inhibitor alleviates sorafenib-induced cardiotoxicity by attenuating KLF11-mediated FSP1-dependent ferroptosis". International Journal of Biological Sciences 20, nr 7 (2024): 2622–39. http://dx.doi.org/10.7150/ijbs.86479.
Pełny tekst źródłaChen, Yiling, Derek Lee, Misty Shuo Zhang, Jacinth Wing-Sum Cheu i Carmen Chak-Lui Wong. "Abstract 3675: Targeting the mevalonate pathway, a novel anti-ferroptosis pathway, in hepatocellular carcinoma (HCC) treatment". Cancer Research 83, nr 7_Supplement (4.04.2023): 3675. http://dx.doi.org/10.1158/1538-7445.am2023-3675.
Pełny tekst źródłaAnne, Gajanan, Ramesh S, Priyaranjan Sharma, Maruthi Prashanth B H, Aditya Kudva S, K. Prakash, Sandeep Sahu i Nagaraj Bhat. "Enhancing wear resistance of AZ61 alloy through friction stir processing: experimental study and prediction model". Materials Research Express, 20.05.2024. http://dx.doi.org/10.1088/2053-1591/ad4e0a.
Pełny tekst źródłaNakamura, Toshitaka, Clara Hipp, André Santos Dias Mourão, Jan Borggräfe, Maceler Aldrovandi, Bernhard Henkelmann, Jonas Wanninger i in. "Phase separation of FSP1 promotes ferroptosis". Nature, 28.06.2023. http://dx.doi.org/10.1038/s41586-023-06255-6.
Pełny tekst źródłaMiyauchi, Wataru, Yuji Shishido, Yoshiaki Matsumi, Tomoyuki Matsunaga, Masahiro Makinoya, Shota Shimizu, Kozo Miyatani i in. "Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma". Esophagus, 28.12.2022. http://dx.doi.org/10.1007/s10388-022-00982-x.
Pełny tekst źródłaLiu, Man-ru, Ce Shi, Qiu-ya Song, Meng-jie Kang, Xin Jiang, Hui Liu i Dong-sheng Pei. "Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma". Hepatology Communications 7, nr 10 (11.09.2023). http://dx.doi.org/10.1097/hc9.0000000000000246.
Pełny tekst źródłaTakahashi, Naoki, Seiji Yokoi, Hideki Kimura, Hironobu Naiki, Taiji Matsusaka, Yasuhiko Yamamoto, Kimihiko Nakatani, Kenji Kasuno i Masayuki Iwano. "Renoprotective effects of extracellular fibroblast specific protein 1 via nuclear factor erythroid 2-related factor-mediated antioxidant activity". Scientific Reports 13, nr 1 (18.12.2023). http://dx.doi.org/10.1038/s41598-023-49863-y.
Pełny tekst źródłaLv, Yun, Chunhui Liang, Qichao Sun, Jing Zhu, Haiyan Xu, Xiaoqing Li, Yao-yao Li i in. "Structural insights into FSP1 catalysis and ferroptosis inhibition". Nature Communications 14, nr 1 (22.09.2023). http://dx.doi.org/10.1038/s41467-023-41626-7.
Pełny tekst źródłaMüller, Fabienne, Jonathan K. M. Lim, Christina M. Bebber, Eric Seidel, Sofya Tishina, Alina Dahlhaus, Jenny Stroh i in. "Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation". Cell Death & Differentiation, 29.11.2022. http://dx.doi.org/10.1038/s41418-022-01096-8.
Pełny tekst źródłaKim, Jong Woo, Min-Ju Kim, Tae-Hee Han, Ji-Yoon Lee, Sangok Kim, Hyerin Kim, Kyoung-Jin Oh i in. "FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner". Cell Death & Disease 14, nr 8 (26.08.2023). http://dx.doi.org/10.1038/s41419-023-06070-x.
Pełny tekst źródła